联合王国的一项研究发现,将尿酸降低到360微克摩尔/升以下、心脏病发作、中风和死亡风险显著降低的凝胶病人。 Gout patients who lower uric acid below 360 µmol/L have significantly lower heart attack, stroke, and death risk, a UK study finds.

联合王国的一项大型研究发现,服用Allopurinol等药物以低于360微摩尔/升(6毫克/dL)的血液尿素水平降低到低于360微摩尔/升(6毫克/dL)的gotut病人在五年内心脏病发作、中风和心血管死亡的风险显著降低。 A large UK study finds that gout patients who take medications like allopurinol to lower blood urate levels below 360 micromol/L (6 mg/dL) have a significantly reduced risk of heart attack, stroke, and cardiovascular death over five years. 研究人员分析了近11万名患有痛风的成年人的数据, 显示那些在一年内达到目标水平的人心血管状况更好, 尤其是那些高风险的人或达到低于300微摩尔/升 (5毫克/分升) 的水平的人. Researchers analyzed data from nearly 110,000 adults with gout, showing that those who achieved target levels within a year had better cardiovascular outcomes, especially those at high risk or who reached even lower levels under 300 micromol/L (5 mg/dL). 这些发表在《美国医学会内科杂志》上的研究结果表明，有效的痛风治疗具有预防复发和改善心脏健康的双重益处。 The findings, published in JAMA Internal Medicine, suggest effective gout treatment offers dual benefits by preventing flares and improving heart health.